Lobbying client
HEMEMICS BIOTECHNOLOGIES, INC.
Biotechnology Firm
Filings
9
Filed by
1
Reported in-house
—
Reported by firms
$80,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2020 to 2023
Filings
9 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
4th Quarter - Termination 4th Quarter 2023
|
BURRELL INTERNATIONAL GROUP LLC | — reported |
|
3rd Quarter - Report 3rd Quarter 2023
|
BURRELL INTERNATIONAL GROUP LLC | $10,000 reported |
|
2nd Quarter - Report 2nd Quarter 2023
|
BURRELL INTERNATIONAL GROUP LLC | $10,000 reported |
|
1st Quarter - Report 1st Quarter 2023
|
BURRELL INTERNATIONAL GROUP LLC | $10,000 reported |
|
4th Quarter - Report 4th Quarter 2022
|
BURRELL INTERNATIONAL GROUP LLC | $10,000 reported |
|
1st Quarter - Termination 1st Quarter 2021
|
BURRELL INTERNATIONAL GROUP LLC | $20,000 reported |
|
1st Quarter - Reportreplaced 1st Quarter 2021
|
BURRELL INTERNATIONAL GROUP LLC | $20,000 reported |
|
4th Quarter - Report 4th Quarter 2020
|
BURRELL INTERNATIONAL GROUP LLC | $20,000 reported |
|
Registration 4th Quarter 2020
|
BURRELL INTERNATIONAL GROUP LLC | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| BURRELL INTERNATIONAL GROUP LLC | 7 | $80,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 6 |
| Medical/Disease Research/Clinical Labs | MED | 2 |
| Budget/Appropriations | BUD | 1 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.